Kalytera Announces Binding Agreement to Acquire Salzman Group
SAN FRANCISCO, May 19, 2020 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") announced today that it has signed a binding Letter of Intent dated May 12, 2020 (the “LOI”) …